Announce Date | 03/26/2024 |
EPS Normalized Actual | $0.537 (Miss by $-0.043) |
EPS GAAP Actual | $0.537 (Miss by $-0.043) |
Revenue Actual | $1.5224B |
Revenue Surprise | Beat by $1522.4M |
Announce Date | 05/31/2024 (Pre-Market) |
EPS Normalized Estimate | $1.34259 |
EPS GAAP Estimate | $1.34259 |
Revenue Estimate | $2.948225B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Nov 2028 | 3.55513 | 18.94 | 3.52098 | 3.66834 | 3 |
Nov 2027 | 3.39144 | 19.86 | 3.35886 | 3.49944 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Feb 2022) | 0.58 | 0.58 | 1.5224B | 2.69% | 1522.4M |
FQ4 2021 (Nov 2021) | 0.737098 | 0.737098 | 1.7303B | 9.96% | 1730.3M |
FQ3 2021 (Aug 2021) | 0.79 | 0.79 | 1.5494B | 7.69% | 1549.4M |
FQ2 2021 (May 2021) | 0.69 | 0.69 | 1.5567B | 10% | 1556.7M |
FQ1 2021 (Feb 2021) | 0.61 | 0.61 | 1.4815B | 18.19% | 1481.5M |
FQ4 2020 (Nov 2020) | 0.75 | 0.75 | 1.5579B | 4.69% | 1557.9M |
FQ3 2020 (Aug 2020) | 0.775 | 0.775 | 1.4303B | 7.07% | 1430.3M |
FQ2 2020 (May 2020) | 0.735 | 0.735 | 1.4011B | 7.08% | 1401.1M |
FQ4 Announce Date
05/31/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
2.948225B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Nov 2026) | 1.02942 | -- | 1.00688 | 1.04705 | 5 |
FQ3 2026 (Aug 2026) | 0.81999 | -- | 0.80204 | 0.83404 | 2 |
FQ2 2026 (May 2026) | 0.70403 | -- | 0.68862 | 0.71609 | 2 |
FQ1 2026 (Mar 2026) | 0.69791 | -- | 0.68362 | 0.72028 | 3 |
FQ4 2025 (Nov 2025) | 0.9557 | -- | 0.93478 | 0.97207 | 3 |
FQ3 2025 (Aug 2025) | 0.74718 | -- | 0.73082 | 0.75998 | 3 |
FQ2 2025 (May 2025) | 0.64925 | -- | 0.63504 | 0.66037 | 4 |
FQ1 2025 (Mar 2025) | 0.64463 | -- | 0.63143 | 0.6653 | 4 |
FQ4 2024 (Nov 2024) | 0.92785 | -- | 0.90754 | 0.94374 | 4 |
FQ3 2024 (Aug 2024) | 0.71134 | -- | 0.70118 | 0.73166 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Nov 2026) | 1.9B | -- | 1.86B | 1.92B | 6 |
FQ3 2026 (Aug 2026) | 1.77B | -- | 1.74B | 1.8B | 3 |
FQ2 2026 (May 2026) | 1.76B | -- | 1.73B | 1.78B | 3 |
FQ1 2026 (Mar 2026) | 1.63B | -- | 1.61B | 1.67B | 3 |
FQ4 2025 (Nov 2025) | 1.83B | -- | 1.8B | 1.85B | 2 |
FQ3 2025 (Aug 2025) | 1.72B | -- | 1.69B | 1.74B | 2 |
FQ2 2025 (May 2025) | 1.69B | -- | 1.66B | 1.71B | 3 |
FQ1 2025 (Mar 2025) | 1.58B | -- | 1.55B | 1.61B | 4 |
FQ4 2024 (Nov 2024) | 1.77B | -- | 1.74B | 1.79B | 5 |
FQ3 2024 (Aug 2024) | 1.67B | -- | 1.64B | 1.7B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Feb 2022) | 0.58 | 0.58 | 100% | |
FQ4 2021 (Nov 2021) | 0.737098 | 0.737098 | 100% | |
FQ3 2021 (Aug 2021) | 0.79 | 0.79 | 100% | |
FQ2 2021 (May 2021) | 0.69 | 0.69 | 100% | |
FQ1 2021 (Feb 2021) | 0.61 | 0.61 | 100% | |
FQ4 2020 (Nov 2020) | 0.75 | 0.75 | 100% | |
FQ3 2020 (Aug 2020) | 0.775 | 0.775 | 100% | |
FQ2 2020 (May 2020) | 0.735 | 0.735 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Feb 2022) | $0B | $1.52B | $1522.4M | 100% |
FQ4 2021 (Nov 2021) | $0B | $1.73B | $1730.3M | 100% |
FQ3 2021 (Aug 2021) | $0B | $1.55B | $1549.4M | 100% |
FQ2 2021 (May 2021) | $0B | $1.56B | $1556.7M | 100% |
FQ1 2021 (Feb 2021) | $0B | $1.48B | $1481.5M | 100% |
FQ4 2020 (Nov 2020) | $0B | $1.56B | $1557.9M | 100% |
FQ3 2020 (Aug 2020) | $0B | $1.43B | $1430.3M | 100% |
FQ2 2020 (May 2020) | $0B | $1.4B | $1401.1M | 100% |